Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$4.61 USD
-0.04 (-0.86%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.62 +0.01 (0.22%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.38 | 9.99 |
Current Quarter Estimate | -0.18 | 3.11 | 61.00 |
Year Ago Quarter Estimate | 0.00 | -4.81 | 54.84 |
Next Quarter Estimate | -0.18 | 3.91 | 63.00 |
Next Year Estimate | -0.58 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -1,325.00 | 17.30 | 15.67 |
Next Year | -18.37 | 9.90 | 11.34 |
Last 5 Years | -45.60 | 0.90 | 8.10 |
Next 5 Years | NA | 21.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.90 |
Price/Book (MRQ) | 0.50 | 2.10 |
Price/Cash Flow (MRFY) | NA | 16.43 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -6.00% | -150.51% |
Return on Equity (TTM) | -2.01% | -61.16% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.